BioCentury
ARTICLE | Financial News

Sage raises $300M follow-on

November 17, 2017 7:35 PM UTC

Sage Therapeutics Inc. (NASDAQ:SAGE) raised $345 million on Nov. 14 through the sale of 4.1 million shares at $85 in a follow-on underwritten by JPMorgan, Goldman Sachs, Morgan Stanley, Cowen and Leerink. The figure includes the sale of a 529,411 share overallotment on Nov. 17...

BCIQ Company Profiles

Sage Therapeutics Inc.

BCIQ Target Profiles

GABA A receptor